These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 9110064

  • 1. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA, Matheron S.
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [Abstract] [Full Text] [Related]

  • 2. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
    Squires KE.
    AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
    [Abstract] [Full Text] [Related]

  • 3. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group.
    AIDS; 1995 May; 9(5):471-7. PubMed ID: 7639972
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of oral ganciclovir in the treatment of cytomegalovirus retinitis in patients with AIDS.
    Ward-Able C, Phillips P, Tsoukas CM.
    CMAJ; 1996 Feb 01; 154(3):363-8. PubMed ID: 8564906
    [Abstract] [Full Text] [Related]

  • 9. Oral ganciclovir effective for CMV.
    Grodeck B.
    Posit Aware; 1995 Feb 01; ():9. PubMed ID: 11362580
    [Abstract] [Full Text] [Related]

  • 10. Ganciclovir implants: one year later.
    Cadman J.
    GMHC Treat Issues; 1997 Feb 01; 11(4/5):3-6. PubMed ID: 11364375
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA.
    Infect Agents Dis; 1995 Sep 01; 4(3):131-42. PubMed ID: 8548191
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL, Stempien MJ, Andrews J, Shadman A, Tan SJ, Miner R, Buhles W.
    J Infect Dis; 1999 Jun 01; 179(6):1352-5. PubMed ID: 10228054
    [Abstract] [Full Text] [Related]

  • 17. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.
    Musch DC, Martin DF, Gordon JF, Davis MD, Kuppermann BD.
    N Engl J Med; 1997 Jul 10; 337(2):83-90. PubMed ID: 9211677
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High dose oral ganciclovir treatment for cytomegalovirus retinitis.
    Lalezari JP, Friedberg DN, Bissett J, Giordano MF, Hardy WD, Drew WL, Hubbard LD, Buhles WC, Stempien MJ, Georgiou P, Jung DT, Robinson CA, Roche Cooperative Oral Ganciclovir Study Group.
    J Clin Virol; 2002 Feb 10; 24(1-2):67-77. PubMed ID: 11744430
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.